Managers / Q4 2019 · view latest →
BARDIN HILL MANAGEMENT PARTNERS LP
CIK 0001616416 · 299 PARK AVENUE, 24TH FLOOR, NEW YORK, NY, 10171 · 2123039478
Summary
Bardin Hill Management Partners LP reported $608M in U.S.-listed holdings across 105 positions for Q4 2019.
Its largest position, Wellcare Health Plans, represents 12.5% of the portfolio.
Compared with Q3 2019, the fund opened 17 new positions and exited 17.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 80.6% · $490M
- Other · 19.1% · $116M
- ETP · 0.3% · $2M
- Right · 0.0% · $238,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| MEDICINES CO | NEW | +415.9K | 415.9K | +$35M | $35M |
| STARS GROUP INC | NEW | +1.03M | 1.03M | +$27M | $27M |
| GENNORTONLIFELOCK INC | NEW | +342.4K | 342.4K | +$22M | $22M |
| AUDENTES THERAPEUTICS INC | NEW | +339.1K | 339.1K | +$20M | $20M |
| TIFFANY & CO | NEW | +146.8K | 146.8K | +$20M | $20M |
| RA PHARMACEUTICALS INC | NEW | +391.8K | 391.8K | +$18M | $18M |
| QGENQIAGEN NV | NEW | +378.9K | 378.9K | +$13M | $13M |
| WRIGHT MED GROUP N V | NEW | +411.7K | 411.7K | +$13M | $13M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2019
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | WELLCARE HEALTH PLANS INC | COM | 12.46% | $76M | 229.4K |
| 2 | ALLERGAN PLC | SHS | 10.96% | $67M | 348.4K |
| 3 | NEXTNEXTDECADE CORPhistory → | COM | 9.54% | $58M | 9.45M |
| 4 | CAESARS ENTMT CORP | COM | 7.02% | $43M | 3.14M |
| 5 | ZAYO GROUP HLDGS INC | COM | 6.15% | $37M | 1.08M |
| 6 | MEDICINES CO | COM | 5.81% | $35M | 415.9K |
| 7 | ADSWADVANCED DISP SVCS INChistory → | COM | 4.63% | $28M | 856.9K |
| 8 | STARS GROUP INC | COM | 4.43% | $27M | 1.03M |
| 9 | EL PASO ELEC CO | COM | 4.24% | $26M | 379.4K |
| 10 | UTXZUNITED TECHNOLOGIES CORPhistory → | COM | 3.97% | $24M | 161.2K |
| 11 | AUDENTES THERAPEUTICS INC | COM | 3.34% | $20M | 339.1K |
| 12 | TIFFANY & CO | COM | 3.23% | $20M | 146.8K |
| 13 | RA PHARMACEUTICALS INC | COM | 3.02% | $18M | 391.8K |
| 14 | QGENQIAGEN NVhistory → | SHS | 2.11% | $13M | 378.9K |
| 15 | WRIGHT MED GROUP N V | ORD SHS | 2.06% | $13M | 411.7K |
| 16 | TALLGRASS ENERGY LP | CLASS A SHS | 1.97% | $12M | 541.5K |
| 17 | TECH DATA CORP | COM | 1.53% | $9M | 64.7K |
| 18 | LOGMEIN INC | COM | 1.52% | $9M | 107.7K |
| 19 | GENNORTONLIFELOCK INChistory → | COM | 1.41% | $9M | 335.8K |
| 20 | INTERXION HOLDING N.V | SHS | 1.28% | $8M | 93.0K |
| 21 | ARQULE INC | COM | 1.28% | $8M | 389.6K |
| 22 | WABCO HLDGS INC | COM | 1.28% | $8M | 57.3K |
| 23 | CCOCLEAR CHANNEL OUTDOOR HLDGShistory → | COM | 1.10% | $7M | 2.33M |
| 24 | ANIXTER INTL INC | COM | 1.04% | $6M | 68.5K |
| 25 | SCHWTHE CHARLES SCHWAB CORPORATI | COM | 0.88% | $5M | 112.7K |
| 26 | FINJAN HLDGS INC | COM | 0.63% | $4M | 1.92M |
| 27 | SANOFI | RIGHT | 0.47% | $3M | 3.30M |
| 28 | TBFPROSHARES TR | SHRT 20+YR TRE | 0.30% | $2M | 93.5K |
| 29 | VISTRA ENERGY CORP | W EXP 02/02/2024 | 0.06% | $392,000 | 180.6K |
| 30 | BRISTOL MYERS SQUIBB CO | RIGHT | 0.04% | $238,000 | 79.2K |
| 31 | PACBPACIFIC BIOSCIENCES CALIF IN | COM | 0.02% | $126,000 | 24.6K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $0 | 1 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $0 | 1 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $80M | 6 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $170M | 41 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $308M | 35 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $210M | 32 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $215M | 65 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | Under review | 63 | Sep 11, 2024 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2024 | $240M | 74 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $235M | 97 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $310M | 93 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $387M | 114 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $405M | 146 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $458M | 159 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $434M | 197 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $384M | 177 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $460M | 183 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $478M | 206 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $619M | 202 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $569M | 238 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $540M | 251 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $479M | 105 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $377M | 87 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $273M | 72 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $457M | 91 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $608M | 105 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $577M | 82 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $723M | 91 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $639M | 91 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $512M | 76 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 4 additional managers.
- Bardin Hill Investment Partners LP
- Bardin Hill Arbitrage Management LP
- Bardin Hill Arbitrage UCITS Management LP
- Bardin Hill Arbitrage IC Management LP
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.